{"id":"https://openalex.org/W2741290782","doi":"https://doi.org/10.1158/1538-7445.am2017-5669","title":"Abstract 5669: Targeting post-surgical breast cancer metastasis through combining natural killer T cell immunotherapy and low dose chemotherapy","display_name":"Abstract 5669: Targeting post-surgical breast cancer metastasis through combining natural killer T cell immunotherapy and low dose chemotherapy","publication_year":2017,"publication_date":"2017-07-01","ids":{"openalex":"https://openalex.org/W2741290782","doi":"https://doi.org/10.1158/1538-7445.am2017-5669","mag":"2741290782"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2017-5669","doi":"https://doi.org/10.1158/1538-7445.am2017-5669","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2017-5669","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064461704","display_name":"Simon Gebremeskel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129902397","display_name":"Dalhousie University","ror":"https://ror.org/01e6qks80","country_code":"CA","type":"education","lineage":["https://openalex.org/I129902397"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Simon Gebremeskel","raw_affiliation_strings":["Dalhousie university, Halifax, Nova Scotia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dalhousie university, Halifax, Nova Scotia, Canada","institution_ids":["https://openalex.org/I129902397"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000760747","display_name":"Kaitlyn Tanner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129902397","display_name":"Dalhousie University","ror":"https://ror.org/01e6qks80","country_code":"CA","type":"education","lineage":["https://openalex.org/I129902397"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Kaitlyn Tanner","raw_affiliation_strings":["Dalhousie university, Halifax, Nova Scotia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dalhousie university, Halifax, Nova Scotia, Canada","institution_ids":["https://openalex.org/I129902397"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057567376","display_name":"Lynnea M. Lobert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129902397","display_name":"Dalhousie University","ror":"https://ror.org/01e6qks80","country_code":"CA","type":"education","lineage":["https://openalex.org/I129902397"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Lynnea Lobert","raw_affiliation_strings":["Dalhousie university, Halifax, Nova Scotia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dalhousie university, Halifax, Nova Scotia, Canada","institution_ids":["https://openalex.org/I129902397"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088476911","display_name":"Brent Johnston","orcid":"https://orcid.org/0000-0001-5456-2824","observed_orcids":["https://orcid.org/0000-0001-5456-2824"]},"institutions":[{"id":"https://openalex.org/I129902397","display_name":"Dalhousie University","ror":"https://ror.org/01e6qks80","country_code":"CA","type":"education","lineage":["https://openalex.org/I129902397"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Brent Johnston","raw_affiliation_strings":["Dalhousie university, Halifax, Nova Scotia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dalhousie university, Halifax, Nova Scotia, Canada","institution_ids":["https://openalex.org/I129902397"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I129902397"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"77","issue":"13_Supplement","first_page":"5669","last_page":"5669"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9574999809265137,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9574999809265137,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.014499999582767487,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.010499999858438969,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/breast-cancer-metastasis","display_name":"breast cancer metastasis","score":0.9279999732971191},{"id":"https://openalex.org/keywords/nkt-cells","display_name":"NKT cells","score":0.8930000066757202},{"id":"https://openalex.org/keywords/low-dose-chemotherapy","display_name":"low-dose chemotherapy","score":0.8769999742507935},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.9089999794960022},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dendritic-cell-vaccination","display_name":"dendritic cell vaccination","score":0.8050000071525574},{"id":"https://openalex.org/keywords/immunogenic-cell-death","display_name":"immunogenic cell death","score":0.8980000019073486},{"id":"https://openalex.org/keywords/myeloid-derived-suppressor-cells","display_name":"myeloid-derived suppressor cells","score":0.9350000023841858},{"id":"https://openalex.org/keywords/4t1-mammary-carcinoma","display_name":"4T1 mammary carcinoma","score":0.9399999976158142},{"id":"https://openalex.org/keywords/tumor-resection","display_name":"tumor resection","score":0.5929999947547913},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5139999985694885},{"id":"https://openalex.org/keywords/tumor-recurrence","display_name":"tumor recurrence","score":0.42399999499320984}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6338402032852173},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.625841498374939},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.597976565361023},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5900388956069946},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.5831013321876526},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5748379230499268},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.5483669638633728},{"id":"https://openalex.org/C139563560","wikidata":"https://www.wikidata.org/wiki/Q224930","display_name":"Natural killer T cell","level":4,"score":0.5396724939346313},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.5377400517463684},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5085972547531128},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.42758694291114807},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4108172357082367},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3735588788986206},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.36541178822517395},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3311324119567871}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2017-5669","doi":"https://doi.org/10.1158/1538-7445.am2017-5669","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2017-5669","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2547397748","https://openalex.org/W2766991138","https://openalex.org/W2966469190","https://openalex.org/W2265669938","https://openalex.org/W2284525586","https://openalex.org/W4244854914","https://openalex.org/W4404924682","https://openalex.org/W4399804702","https://openalex.org/W2913665379","https://openalex.org/W2736729143"],"abstract_inverted_index":{"Abstract":[0],"Breast":[1],"cancer":[2,7,17,255,328],"is":[3],"the":[4,12,122,157,218,252,261,312,345],"most":[5,21],"common":[6],"in":[8,71,84,180,231,257,311],"Canadian":[9],"women":[10],"and":[11,27,66,135,206,220,248,269,292,337],"second":[13],"leading":[14],"cause":[15],"of":[16,30,54,87,125,152,170,177,223,254,263,282,344],"deaths.":[18],"Given":[19],"that":[20,57,78],"mammary":[22,116,123],"tumors":[23],"are":[24,34,43,50,93],"surgically":[25],"resectable":[26],"over":[28],"90%":[29],"breast":[31,90,327],"cancer-associated":[32],"deaths":[33],"due":[35],"to":[36,61,98,109,286,307],"metastasis,":[37],"new":[38],"therapeutic":[39],"strategies":[40],"targeting":[41],"metastasis":[42,205,291,329],"required.":[44],"Natural":[45],"killer":[46,333],"T":[47,334],"(NKT)":[48],"cells":[49,56,118,147,154,179,202,227,256],"a":[51,85,297],"rare":[52],"population":[53],"immune":[55],"have":[58,76],"been":[59],"shown":[60,77],"limit":[62],"primary":[63],"tumor":[64,233,241,245,290],"growth":[65,242],"target":[67,308],"distant":[68],"metastatic":[69,89,309],"disease":[70,310],"various":[72],"animal":[73],"models.":[74],"We":[75,92,161],"NKT":[79,101,146,186,214,271,304],"cell":[80,102,175,187,215,272,305,335],"activation":[81,103,188,216,273],"improves":[82],"survival":[83],"model":[86],"post-surgical":[88,326],"cancer.":[91],"now":[94],"expanding":[95],"this":[96],"work":[97,295],"determine":[99],"whether":[100,164],"can":[104,275],"be":[105,277],"combined":[106,278],"with":[107,139,156,196,279,303],"chemotherapies":[108],"improve":[110],"outcomes.":[111],"In":[112],"our":[113],"model,":[114],"4T1":[115,178],"carcinoma":[117],"were":[119,130,137,148],"injected":[120],"into":[121],"fatpad":[124],"syngeneic":[126],"BALB/c":[127],"mice.":[128],"Tumors":[129],"resected":[131],"at":[132],"day":[133,144],"12,":[134],"mice":[136,238],"treated":[138],"cyclophosphamide":[140,285],"or":[141,166,199,284],"gemcitabine.":[142],"On":[143],"17,":[145],"activated":[149],"by":[150,191,259],"transfer":[151],"dendritic":[153,201],"loaded":[155],"glycolipid":[158],"antigen":[159],"\u03b1-GalCer.":[160],"also":[162,250],"examined":[163],"gemcitabine":[165,283],"mafosphamide":[167,249],"(active":[168],"component":[169],"cyclophosphamide)":[171],"would":[172],"induce":[173],"immunogenic":[174],"death":[176],"culture.":[181],"Chemotherapeutics":[182],"did":[183],"not":[184],"affect":[185],"as":[189,236],"measured":[190],"serum":[192],"IFN\u03b3":[193],"levels.":[194],"Treatment":[195],"cyclophosphamide,":[197],"gemcitabine,":[198],"\u03b1-GalCer-loaded":[200],"alone":[203],"reduced":[204],"prolonged":[207],"survival.":[208,213],"Combined":[209],"treatments":[210],"significantly":[211],"enhanced":[212,232],"decreased":[217],"frequency":[219],"immunosuppressive":[221],"function":[222],"myeloid":[224],"derived":[225],"suppressor":[226],"(MDSCs).":[228],"Treatments":[229],"resulted":[230],"specific":[234],"immunity":[235],"surviving":[237],"exhibited":[239],"slower":[240],"following":[243],"secondary":[244],"challenge.":[246],"Gemcitabine":[247],"increase":[251],"immunogenicity":[253],"vitro":[258],"increasing":[260],"exposure/release":[262],"MHCI,":[264],"MHCII,":[265],"CD1d,":[266],"Calreticulin,":[267],"HMGB1":[268],"ATP.":[270],"therapy":[274],"successfully":[276],"low":[280,338],"doses":[281],"enhance":[287],"protection":[288],"against":[289],"recurrence.":[293],"This":[294],"provides":[296],"clear":[298],"rationale":[299],"for":[300,348],"combining":[301,331],"chemotherapy":[302,340],"immunotherapy":[306,336],"clinical":[313],"setting.":[314],"Citation":[315],"Format:":[316],"Simon":[317],"Gebremeskel,":[318],"Kaitlyn":[319],"Tanner,":[320],"Lynnea":[321],"Lobert,":[322],"Brent":[323],"Johnston.":[324],"Targeting":[325],"through":[330],"natural":[332],"dose":[339],"[abstract].":[341],"In:":[342],"Proceedings":[343],"American":[346],"Association":[347],"Cancer":[349,362],"Research":[350],"Annual":[351],"Meeting":[352],"2017;":[353],"2017":[354],"Apr":[355],"1-5;":[356],"Washington,":[357],"DC.":[358],"Philadelphia":[359],"(PA):":[360],"AACR;":[361],"Res":[363],"2017;77(13":[364],"Suppl):Abstract":[365],"nr":[366],"5669.":[367],"doi:10.1158/1538-7445.AM2017-5669":[368]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2017-08-08T00:00:00"}